HealthFDA scientists opposed Trump administration’s move to ease access to peptides
Most FDA scientific staff opposed a plan favored by Health Secretary Robert F. Kennedy Jr. to ease access to unproven injectable peptides, according to six people familiar with its development. The HHS policy directs the FDA not to act against specialty pharmacies selling several of the substances.
People in this report Donald Trump
TThe Guardian★★★☆☆2026-10-28 18:35Original
FDA scientists opposed Trump administration’s move to ease access to peptides
Health